Author:
Strand Douglas W.,Aaron LaTayia,Henry Gervaise,Franco Omar E.,Hayward Simon W.
Funder
National Center for Advancing Translational Sciences
Vanderbilt Institute for Clinical and Translational Research
Subject
Cancer Research,Cell Biology,Developmental Biology,Molecular Biology
Reference107 articles.
1. Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group;Anon;Prostate,1993
2. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer;Antonarakis;N. Engl. J. Med.,2014
3. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium;Ao;Cancer Res.,2007
4. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer;Ayala;Clin. Cancer Res.,2003
5. Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue;Bauman;Am. J. Clin. Exp. Urol.,2014
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献